InsidersTradesSigma
Track the AKANDA CORP. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.9m. The latest transaction was reported on 20 January 2026 (Acquisition). Among the most active insiders: HRT FINANCIAL LP. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€34,904
1 ops.
Buy Volume
€8,743
1 ops.
Sell Volume
14Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 January 2026
Declarations2 total
29,036 shares@ US$1.4080.0% of flowClass A SharesSEC:0001475597-26-000002:0
Canonical exit: 15 Apr 2026 (T+90)
7,868 shares@ US$1.2920.0% of flowClass A SharesSEC:0001475597-26-000002:1
2 of 2 declarations
About AKANDA CORP.
AKANDA CORP. is a company listed on the XNAS market. It specializes in the health and pharmaceutical sector.